Site under construction

Since more than 50 years, S.M.B. uses its experience, its know-how and the best existing technologies to identify and develop its own pharmaceutical forms that are designed to improve patients outcomes. The goal of S.M.B’s galenical development is to achieve better efficacy and better tolerance of the medicine and thus better patient compliance. In S.M.B., R&D is perhaps the most vocational activity, while at the same time, being involved into the medicine production and marketing activity that allows us to maintain our independence as a company.

For Southern Europe, Eastern Europe
& CIS, Middle East :

Nicolas BISCHLER
Business Development Manager
nbisc@smb.be